Discriminant Radiomic Feature Selection for PD-L1 Prediction in Clear Cell Renal Cell Carcinoma

被引:0
|
作者
Wu, Yixing [1 ]
Shieh, Alexander [2 ]
Cen, Steven [2 ]
Varghese, Bino [2 ]
Hwang, Darryl H. [2 ]
Wallace, William [2 ]
Kuo, C. -C. Jay [1 ]
Duddalwar, Vinay [2 ]
机构
[1] Univ Southern Calif, Media Commun Lab, Los Angeles, CA 90007 USA
[2] Univ Southern Calif, Dept Radiol, Los Angeles, CA USA
来源
2023 19TH INTERNATIONAL SYMPOSIUM ON MEDICAL INFORMATION PROCESSING AND ANALYSIS, SIPAIM | 2023年
关键词
Radiomics; Multiplex immunofluorescence; Green Learning; Discriminant Feature Test; Least-square Normal Transform;
D O I
10.1109/SIPAIM56729.2023.10373476
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer. Previously, researchers explored the concept of utilizing radiomic features from multiphase computer tomography (CT) imaging to predict the tumor immune microenvironment (TIME) measurements, such as the PD-L1 levels, from multiplex immunofluorescence (mIF) images. PD-L1 is an important prognostic marker for ccRCC and CT radiomics can be a non-invasive modality to predict PD-L1. However, prediction performance in the prior work is still limited. This could be due to the limitation of either the underlying nature of these associations, the richness of imaging features, or the capabilities of supervised learning algorithms. This work implements two Green Learning (GL) methods discriminant feature test (DFT) and least-square normal transform (LNT) to improve predictive performance while minimizing model complexity. We observed a significant improvement in the radiomics prediction performance of tumor epithelium PD-L1 >1%, >5% and PD-L1>10%. Compared to prior research, the AUROC values improved from 0.61 to 0.76, 0.75 to 0.85 and 0.85 to 0.88, respectively.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] ENHANCED CT RADIOMICS PREDICTION OF CLEAR CELL RENAL CELL CARCINOMA PD-L1 EXPRESSION WITH ADAPTIVE FEATURE ENGINEERING STRATEGIES
    Wu, Yixing
    Shieh, Alexander
    Jogi, Pawan
    Cen, Steven
    Wallace, William Dean
    Kuo, Jay
    Duddalwar, Vinay
    JOURNAL OF UROLOGY, 2024, 211 (05): : E498 - E498
  • [2] PD-L1 expression in non-clear cell renal cell carcinoma.
    Fay, Andre P.
    Callea, Marcella
    Gray, Kathryn P.
    Thai Huu Ho
    Song, Jiaxi
    Carvo, Ingrid
    Lampron, Megan E.
    Stanton, Melissa L.
    McDermott, David F.
    Atkins, Michael B.
    Freeman, Gordon J.
    Hirsch, Michelle S.
    Signoretti, Sabina
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [3] Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma
    Larrinaga, Gorka
    Solano-Iturri, Jon Danel
    Errarte, Peio
    Unda, Miguel
    Loizaga-Iriarte, Ana
    Perez-Fernandez, Amparo
    Echevarria, Enrique
    Asumendi, Aintzane
    Manini, Claudia
    Angulo, Javier C.
    Lopez, Jose I.
    CANCERS, 2021, 13 (04) : 1 - 17
  • [4] PD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosis
    Katia R M Leite
    Sabrina T. Reis
    José Pontes Junior
    Marcelo Zerati
    Daniel de Oliveira Gomes
    Luiz H. Camara-Lopes
    Miguel Srougi
    Diagnostic Pathology, 10
  • [5] PD-L1 expression is regulated by hypoxia inducible factor in clear cell renal cell carcinoma
    Ruf, Melanie
    Moch, Holger
    Schraml, Peter
    INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (02) : 396 - 403
  • [6] PD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosis
    Leite, Katia R. M.
    Reis, Sabrina T.
    Pontes Junior, Jose
    Zerati, Marcelo
    Gomes, Daniel de Oliveira
    Camara-Lopes, Luiz H.
    Srougi, Miguel
    DIAGNOSTIC PATHOLOGY, 2015, 10
  • [7] PD-L1 Expression in Clear Cell Renal Cell Carcinoma: An Analysis of Nephrectomy and Sites of Metastases
    Jilaveanu, L. B.
    Shuch, B.
    Zito, C. R.
    Parisi, F.
    Barr, M.
    Kluger, Y.
    Chen, L.
    Kluger, H. M.
    JOURNAL OF CANCER, 2014, 5 (03): : 166 - 172
  • [8] Immunohistochemical study of PD-L1 and CD8 in clear cell renal cell carcinoma
    Azueta, A.
    Marcos Gonzalez, S.
    Hoz Fernandez, J.
    Grande Gozalez, L.
    Diaz Garcia, M. P.
    Freire Salinas, J.
    Garcia Arranz, M. P.
    Rodriguez Villar, D.
    Gomez-Roman, J.
    VIRCHOWS ARCHIV, 2020, 477 : S156 - S156
  • [9] Dissection of PD-L1 promoter reveals differential transcriptional regulation of PD-L1 in VHL mutant clear cell renal cell carcinoma
    Kong, Su-Kang
    Kim, Byung Soo
    Lim, Hyangsoon
    Kim, Hyun Ji
    Kim, Young-Sik
    LABORATORY INVESTIGATION, 2022, 102 (04) : 352 - 362
  • [10] Evaluation of PD-L1 expression in PBRM1-altered clear cell renal cell carcinoma
    Lee, Jieun
    Moon, Seyoung
    Kwon, Hyun Jung
    Lee, Sejoon
    Choe, Gheeyoung
    Lee, Kyu Sang
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (12) : 454e21 - 454e30